Content reviewed by clinical research staff

Last reviewed: March 2026Sources: PubMed, FDA, WADA Prohibited List

Evidence graded using the PeptideScholar A-D system.

Tesamorelin

GHRH analog44 amino acidsBrand: Egrifta, Egrifta SV

AFDA Approved
95
Excellent Credibility
3 cited studies | Evidence level A

Tesamorelin is a synthetic GHRH analog approved by the FDA as Egrifta for reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.

Mechanism of Action

Binds to GHRH receptors and stimulates pituitary production and release of endogenous growth hormone. The trans-3-hexenoic acid modification increases receptor binding stability.

Benefits

  • FDA-approved reduction of visceral adipose tissue[1]
  • Reduced liver fat (NAFLD) in clinical trials[2]
  • Improved triglyceride levels[1]
  • Maintained cognitive function in aging studies[3]
Not medical advice - research-reported information only

This content is for informational purposes only and does not constitute medical advice.

Tesamorelin - Dosing in Published Research

Reported routes: Subcutaneous injection
FDA-approved dose: 2 mg SC once daily. Treatment should be discontinued if no reduction in visceral fat after 6 months.

The dosing information above is sourced from published research literature and clinical trials. These are not recommendations. Individual responses vary. Always consult a healthcare provider before considering any peptide-based therapy.

Side Effects

  • Injection site reactions (erythema, pruritus)[1]
  • Arthralgia[1]
  • Peripheral edema[1]
  • Myalgia[1]
  • Increased risk of fluid retention[1]

Discuss Tesamorelin with a doctor

Tesamorelin is FDA-approved and available by prescription. Licensed telehealth providers can evaluate if it's right for you.

Get the Provider Checklist

Start with the evidence and provider checklist while routing is offline.

FDA approvedBoard-certified doctorsPrescription if appropriate

PeptideScholar may receive compensation from provider referrals. This does not influence our editorial content.

Approved Treatment Routing

Tesamorelin in PeptideScholar's approved-treatment dataset

Tesamorelin is currently modeled on this site as an approved treatment path for: Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Brand names in the current dataset: Egrifta, Egrifta SV.

Validation note: This block reflects the site's current structured treatment data and internal routing logic. It is not a substitute for checking current prescribing, labeling, payer, or local regulatory details.
Treatment Hub
Tesamorelin Treatment Guide

Approved product paths, real cost friction, provider routing, and tracker next steps — all in one source-backed hub.

Open treatment hub →

Research & Evidence

Compare Tesamorelin With

References

  1. 1.Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.. Drugs, 2011. "26-week trial showed significant reduction in visceral adipose tissue vs placebo in HIV lipodystrophy" [PMID: 21668043]
  2. 2.Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.. Lancet HIV, 2019. "Tesamorelin reduced hepatic fat fraction by 37% in HIV-infected patients with fatty liver" [PMID: 31611038]
  3. 3.Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.. Arch Neurol, 2012. "Tesamorelin preserved cognitive function and reduced brain amyloid in at-risk adults over 20 weeks" [PMID: 22869065]

Recommended Resources

The Peptide Protocols Handbook

Evidence-based reference guide covering mechanisms, research, and clinical applications.

View on Amazon

Third-Party Peptide Testing

Independent lab analysis to verify peptide purity and authenticity.

Learn More

Links may be affiliate links. See our disclosure.

Recovery Support Products

Tools and supplements commonly used alongside hormone optimization protocols.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Progress Tracking Tools

Monitor body composition, sleep, and recovery metrics.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.